Riskpilot← Back to searchSign inGet full accessRectus Nordic ApS
APSActiveCVR 39019248Møgelgårdsvej 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20174 employees
Revenue 2024
DKK 1,9M
-9% vs 2023
EBITDA margin
13.9%
+46% vs 2023
Equity ratio
47.7%
Financial strength
Net profit 2024
DKK 127K
+1% vs 2023
| Revenue | DKK 1,9M | -9% |
| EBITDA | DKK 267K | +46% |
| Net profit | DKK 127K | +1% |
| Total assets | DKK 2M | -3% |
| Equity | DKK 971K | +15% |
| Employees | 4 | — |
Legal name
Rectus Nordic ApS
CVR number
39019248
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. oktober 2017
Share capital
DKK 50.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er investering, industri, handel og håndværk samt en efter direktionens skøn beslægtet form for virksomhed
Address
Møgelgårdsvej 11
Phone
+4586141517
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.501 | 2.093 | 2.045 | 2.109 | 1.912 |
| Staff expenses | -2.156 | -1.924 | -2.075 | -1.926 | -1.645 |
| EBITDA | 345 | 163 | -30 | 183 | 267 |
| Depreciation & amort. | -59 | -70 | -82 | -21 | -10 |
| EBIT | 286 | 93 | -112 | 162 | 257 |
| Net financials | -22 | -29 | -48 | -26 | -41 |
| Profit before tax | 264 | 63 | -161 | 136 | 216 |
| Tax | 61 | 26 | -33 | 9 | 89 |
| Net profit | 203 | 38 | -128 | 126 | 127 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.981 | 2.016 | 1.905 | 2.100 | 2.038 |
| Equity | 914 | 851 | 723 | 844 | 971 |
| Long-term debt | 168 | 0 | 0 | 0 | 0 |
| Short-term debt | 899 | 1.160 | 1.182 | 1.256 | 1.067 |
| Total debt | 1.067 | 1.160 | 1.182 | 1.256 | 1.067 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20202024
Equity ratio
47.7%
This company
38.2%
Market median
+25% vs market
20202024
Return on equity
13.1%
This company
18.4%
Market median
+29% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20202024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EP Management | Management | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PROMOVENTUS ApS
Rectus Nordic ApS Board members of Rectus Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Petersen | Management | 0 companies |
| Flemming Petersen | Chairman | 0 companies |
| Alexander Køppen Petersen | Board of Directors | 0 companies |
| Marianne Køppen | Board of Directors | 0 companies |